Related Experiment Video
Updated: Sep 17, 2025

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
Validation of Bayesian modeling approach of uncertainty in organ doses using post-mortem measurements
Maia Avtandilashvili1, Martin Šefl2,3, Joey Y Zhou4
1United States Transuranium and Uranium Registries, College of Pharmacy and Pharmaceutical Sciences, Washington State University, 1845 Terminal Drive, Suite 201, Richland, WA, 99354, USA. m.avtandilashvili@wsu.edu.
Abstract:
The biokinetic and dosimetry models recommended by the International Commission on Radiological Protection do not incorporate dosimetric uncertainty. Recently, Bayesian approach-offering distribution of dose estimates rather than a single point value-has been applied in epidemiological risk modeling. Although the true dose is unknown, Bayesian analysis is assumed to provide information on the true dose through a posterior distribution. This study presents a unique opportunity to validate that assumption. Radiation dose is directly related to the time-dependent radionuclide activity deposited or retained in organs and tissues. Therefore, uncertainties in organ activity predictions derived from biokinetic modeling can serve as proxies for the uncertainties in dose estimation. In this study, uncertainties in model predictions of 239Pu organ activities were evaluated for 20 former nuclear workers with known plutonium inhalation. Ten individuals from Los Alamos were primarily exposed to soluble Pu-nitrate, while ten from Rocky Flats were exposed to insoluble PuO2. All individuals were volunteer tissue donors to the United States Transuranium and Uranium Registries. Urine bioassay data and post-mortem measurements of 239Pu in the liver, skeleton and respiratory tract were used in the analysis. Latin hypercube sampling was employed to generate parameter sets for each realization, varying only two parameters of the human respiratory tract model: the rapidly dissolved fraction, fr and slow dissolution rate, ss. For each realization: (i) intake was estimated using maximum likelihood fitting of the urine bioassay data, and (ii) post-mortem organ activities, used as surrogates of true doses, were predicted based on the estimated intake. Predicted distributions of 239Pu organ activities were compared to point estimates based on default parameters for soluble and insoluble plutonium, as well as to the measured post-mortem values. Results showed that in most cases, the predicted distributions did not cover the measured values (75% for liver, 90% for skeleton, and 50% for the respiratory tract), indicating a need to improve current biokinetic models. Additionally, in some cases, the model predictions were not conservative, which raises concerns from a radiation protection standpoint.
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Physiological Models
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Propagation of Uncertainty from Systematic Error
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

